1. P40. Delta-9-Tetrahydrocannabinol-cannabidiol (THC/CBD) oromucosal spray for the treatment of spasticity in ALS – Assessment of patient reported outcomes. Issue 8 (August 2018) Authors: Funke, A.; Spittel, S.; Kettemann, D.; Maier, A.; Münch, C.; Meyer, T. Journal: Clinical neurophysiology Issue: Volume 129:Issue 8(2018:Aug.) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P43. Dysphagia and difficulties with tablet intake in ALS – Assessment from the patient perspective. Issue 8 (August 2018) Authors: Maier, A.; Spittel, S.; Funke, A.; Kettemann, D.; Münch, C.; Meyer, T. Journal: Clinical neurophysiology Issue: Volume 129:Issue 8(2018:Aug.) Page Start: e84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗